Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-001971
Filing Date
2025-01-23
Accepted
2025-01-23 18:22:21
Documents
2
Period of Report
2025-01-21

Document Format Files

Seq Description Document Type Size
1 form3-01232025_110117.html 3  
1 form3-01232025_110117.xml 3 3257
2 ex24-01232025_110117.htm EX-24 3998
  Complete submission text file 0001415889-25-001971.txt   8697
Mailing Address C/O SIERRA ONCOLOGY, INC. 1820 GATEWAY DRIVE, SUITE 110 SAN MATEO CA 94404
Business Address
Klencke Barbara (Reporting) CIK: 0001647647 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39386 | Film No.: 25551225

Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Issuer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)